Healthpeak Properties (HC5) Stock Forecast & Price Target
HC5 Analyst Ratings
Hold
2Buy11Hold0Sell
Based on 13 analysts giving stock ratings to Healthpeak Properties in the past 3 months
HC5 Stock 12 Month Forecast
Average Price Target
EUR 19.40▲(13.88% Upside)Based on 13 Wall Street analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is EUR 19.40 with a high forecast of EUR 22.32 and a low forecast of EUR 16.96. The average price target represents a 13.88% change from the last price of EUR 17.03.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 22.32
AverageEUR 19.40
LowEUR 16.96
Highest Price TargetHighestEUR 22.32Average Price TargetEUR 19.40Lowest Price TargetLowestEUR 16.96
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Kilichowski | Wells Fargo | EUR 19.64→EUR 16.96 | hold | -0.42%Downside | Assigned | 10/19/26 | ||
| Richard Hightower | Barclays | EUR 21.43→EUR 18.75 | hold | 10.07%Upside | Reiterated | 10/13/26 | ||
| Michael Goldsmith | UBS | EUR 19.20→EUR 17.86 | hold | 4.83%Upside | Assigned | 10/13/26 | ||
| Dave Rodgers | Raymond James | ― | hold | ― | Reiterated | 10/06/26 | ||
| Richard Anderson | Cantor Fitzgerald | ― | hold | ― | Reiterated | 09/28/26 | ||
| James Kammert | Evercore ISI | EUR 20.54→EUR 19.64 | hold | 15.31%Upside | Reiterated | 09/21/26 | ||
| Joe Dickstein | Jefferies | EUR 19.64→EUR 18.75 | hold | 10.07%Upside | Initiated | 09/15/26 | ||
| Farrell Granath | Bank of America Securities | EUR 21.43→EUR 22.32 | buy | 31.03%Upside | Reiterated | 08/24/26 | ||
| Michael Mueller | J.P. Morgan | EUR 19.64 | hold | 15.31%Upside | Reiterated | 08/18/26 | ||
| Nicholas Joseph | Citi | EUR 17.86→EUR 19.64 | hold | 15.31%Upside | Reiterated | 08/11/26 | ||
| Michael Carroll | RBC Capital | EUR 18.75→EUR 21.43 | buy | 25.79%Upside | Reiterated | 08/10/26 | ||
| Ronald Kamdem | Morgan Stanley | EUR 19.64 | hold | 15.31%Upside | Reiterated | 08/05/26 | ||
| Nicholas Yulico | Scotiabank | EUR 18.75 | hold | 10.07%Upside | Reiterated | 08/05/26 | ||
| Vikram Malhotra | Mizuho Securities | EUR 18.75→EUR 21.43 | buy | 25.79%Upside | Reiterated | 07/06/26 | ||
| Juan C. Sanabria | BMO Capital | EUR 17.86→EUR 21.43 | buy | 25.79%Upside | Reiterated | 06/15/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| John Kilichowski | 10/19/26 | EUR 19.64→EUR 16.96 | hold | -0.42%Downside | Assigned | Wells Fargo | ||
| Richard Hightower | 10/13/26 | EUR 21.43→EUR 18.75 | hold | 10.07%Upside | Reiterated | Barclays | ||
| Michael Goldsmith | 10/13/26 | EUR 19.20→EUR 17.86 | hold | 4.83%Upside | Assigned | UBS | ||
| Dave Rodgers | 10/06/26 | ― | hold | ― | Reiterated | Raymond James | ||
| Richard Anderson | 09/28/26 | ― | hold | ― | Reiterated | Cantor Fitzgerald | ||
| James Kammert | 09/21/26 | EUR 20.54→EUR 19.64 | hold | 15.31%Upside | Reiterated | Evercore ISI | ||
| Joe Dickstein | 09/15/26 | EUR 19.64→EUR 18.75 | hold | 10.07%Upside | Initiated | Jefferies | ||
| Farrell Granath | 08/24/26 | EUR 21.43→EUR 22.32 | buy | 31.03%Upside | Reiterated | Bank of America Securities | ||
| Michael Mueller | 08/18/26 | EUR 19.64 | hold | 15.31%Upside | Reiterated | J.P. Morgan | ||
| Nicholas Joseph | 08/11/26 | EUR 17.86→EUR 19.64 | hold | 15.31%Upside | Reiterated | Citi | ||
| Michael Carroll | 08/10/26 | EUR 18.75→EUR 21.43 | buy | 25.79%Upside | Reiterated | RBC Capital | ||
| Ronald Kamdem | 08/05/26 | EUR 19.64 | hold | 15.31%Upside | Reiterated | Morgan Stanley | ||
| Nicholas Yulico | 08/05/26 | EUR 18.75 | hold | 10.07%Upside | Reiterated | Scotiabank | ||
| Vikram Malhotra | 07/06/26 | EUR 18.75→EUR 21.43 | buy | 25.79%Upside | Reiterated | Mizuho Securities | ||
| Juan C. Sanabria | 06/15/26 | EUR 17.86→EUR 21.43 | buy | 25.79%Upside | Reiterated | BMO Capital |
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
Best Analysts Covering Healthpeak Properties
3 Months
Success Rate16/28 ratings generated profit
57%
Average Return
+1.27%
Copying Juan C. Sanabria's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +1.27% per trade.
1 Year
Success Rate12/28 ratings generated profit
43%
Average Return
+4.05%
Copying Michael Carroll's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +4.05% per trade.
2 Years
Success Rate16/28 ratings generated profit
57%
Average Return
+5.15%
Copying Michael Carroll's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +5.15% per trade.
HC5 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 11 | 8 | 4 | 3 | 2 |
| Hold | 12 | 14 | 18 | 19 | 17 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 22 | 22 | 22 | 19 |
In the current month, HC5 has received 2 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. HC5 average Analyst price target in the past 3 months is 19.40.
HC5 Financial Forecast
HighEUR 0.16
ConsensusEUR 0.06
LowEUR 0.02
HC5 Earnings Forecast
Next quarter’s earnings estimate for HC5 is EUR 0.06 with a range of EUR 0.02 to EUR 0.16. The previous quarter’s EPS was EUR 0.07. Its overall industry beat the EPS estimate 54.52% of the time in the past 12 months.
HighEUR 683M
ConsensusEUR 664M
LowEUR 633M
HC5 Sales Forecast
Next quarter’s sales forecast for HC5 is EUR 664.47M with a range of EUR 633.47M to EUR 682.73M. The previous quarter’s sales results were EUR 693.59M. Its overall industry beat sales estimates 73.09% of the time in the past 12 months.
HC5 Stock Forecast FAQ
What is DE:HC5’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthpeak Properties’s 12-month average price target is €19.40.
What is DE:HC5’s upside potential, based on the analysts’ average price target?
Healthpeak Properties has 13.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Healthpeak Properties a Buy, Sell or Hold?
Healthpeak Properties has a consensus rating of Hold, which is based on 2 buy ratings, 11 hold ratings and 0 sell ratings.
What is Healthpeak Properties’s share price target?
The average share price target for Healthpeak Properties is €19.40. This is based on 13 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €22.32, and the lowest forecast is €16.96. The average share price target represents a 13.88% increase from the current price of €17.035.
What do analysts say about Healthpeak Properties?
Healthpeak Properties’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Street analysts.
How can I buy shares of Healthpeak Properties?
To buy shares of DE:HC5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.